• 1. Dissociation of aryl sulfonyl phthalimide radical anions: relevance to the biological activity of arylsulfonyl amides?
  Abdelaziz Houmam,Emad M. Hamed Chem. Commun., 2012,48, 11328-11330
• 2. Excimer and exciplex formation in a pair of bright phosphorescent isomers constructed from Cu3(pyrazolate)3 and Cu3I3 coordination luminophores?
  Shun-Ze Zhan,Mian Li,Xiao-Ping Zhou,Dan Li,Seik Weng Ng RSC Adv., 2011,1, 1457-1459
• 3. Fe(iii)-mediated isomerization of α,α-diarylallylic alcohols to ketones via radical 1,2-aryl migration?
  Ziyang Deng,Changwei Chen,Sunliang Cui RSC Adv., 2016,6, 93753-93755
• 4. Examination of deposit in commercial diluted phosphoric acid
  Analyst, 1880,5, 146-147
• 5. Dissociative electron attachment to HGaF4 Lewis–Br?nsted superacid
  Marcin Czapla,Jack Simons Phys. Chem. Chem. Phys., 2018,20, 21739-21745

Professional Introduction to Compound with CAS No. 1000933-89-0 and Product Name: 8-Fluoroquinoline-5-sulfonyl chloride

8-Fluoroquinoline-5-sulfonyl chloride (CAS No. 1000933-89-0) is a specialized organic compound that has garnered significant attention in the field of pharmaceutical chemistry and medicinal research. This compound belongs to the quinoline class of heterocyclic aromatic compounds, which are widely recognized for their diverse biological activities and therapeutic potential. The introduction of a fluorine atom at the 8-position and a sulfonyl chloride group at the 5-position enhances its chemical reactivity and functional properties, making it a valuable intermediate in the synthesis of various pharmacologically active molecules.

The structure of 8-Fluoroquinoline-5-sulfonyl chloride exhibits a unique arrangement of functional groups that contribute to its distinct chemical behavior. The fluorine atom, being highly electronegative, influences the electronic distribution within the molecule, thereby affecting its reactivity and interaction with biological targets. The sulfonyl chloride group, on the other hand, is known for its strong electrophilic nature, which makes it an excellent leaving group in nucleophilic substitution reactions. This combination of features positions 8-Fluoroquinoline-5-sulfonyl chloride as a versatile building block in organic synthesis.

In recent years, there has been a surge in research focused on developing novel antimicrobial agents due to the increasing prevalence of drug-resistant pathogens. Quinoline derivatives have long been recognized for their antimicrobial properties, and modifications such as fluorination have further enhanced their efficacy. The fluorinated quinoline scaffold has shown promise in combating Gram-negative bacteria, including those that are resistant to conventional antibiotics. Studies have demonstrated that the introduction of fluorine atoms can improve bacterial uptake and binding affinity to target enzymes, thereby increasing the potency of the compound.

One of the most compelling applications of 8-Fluoroquinoline-5-sulfonyl chloride is in the development of kinase inhibitors. Kinases are enzymes that play a crucial role in cell signaling pathways and are implicated in various diseases, including cancer. By modifying the quinoline core with fluorine and sulfonyl chloride groups, researchers have been able to design molecules that selectively inhibit specific kinases. For instance, derivatives of this compound have shown inhibitory activity against tyrosine kinases, which are overexpressed in many cancer cell lines. This has opened up new avenues for the development of targeted therapies.

The synthesis of 8-Fluoroquinoline-5-sulfonyl chloride involves multi-step organic reactions that require precise control over reaction conditions. Typically, the synthesis begins with the fluorination of quinoline at the 8-position followed by sulfonylation at the 5-position using a chlorosulfonic acid derivative. Advanced synthetic techniques such as palladium-catalyzed cross-coupling reactions have also been employed to achieve higher yields and purities. These synthetic strategies highlight the compound's importance as a key intermediate in pharmaceutical manufacturing.

From a medicinal chemistry perspective, 8-Fluoroquinoline-5-sulfonyl chloride serves as a valuable scaffold for structure-activity relationship (SAR) studies. By systematically varying substituents on the quinoline ring, researchers can gain insights into how different functional groups influence biological activity. This information is crucial for optimizing drug candidates for better efficacy and reduced side effects. The compound's versatility allows it to be incorporated into diverse molecular architectures, making it an indispensable tool in drug discovery pipelines.

The pharmacokinetic properties of derivatives derived from 8-Fluoroquinoline-5-sulfonyl chloride are another area of active investigation. Fluorinated compounds often exhibit improved metabolic stability and oral bioavailability, which are critical factors for therapeutic success. Preclinical studies have shown that certain derivatives exhibit favorable pharmacokinetic profiles, including prolonged half-life and reduced clearance rates. These findings suggest that compounds based on this scaffold could be developed into orally administered drugs with enhanced therapeutic windows.

In conclusion,8-Fluoroquinoline-5-sulfonyl chloride (CAS No. 1000933-89-0) is a multifaceted compound with significant potential in pharmaceutical research and development. Its unique structural features make it an excellent intermediate for synthesizing biologically active molecules with applications ranging from antimicrobial agents to kinase inhibitors. The ongoing research into its derivatives underscores its importance as a cornerstone in modern drug discovery efforts.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)